Search PubMed⌕ Search

Biomedical subjects

S Grzybowski

Publications and source records attributed to S Grzybowski.

At least 91 records · Page 5Linked to original sources

Chemoprophylaxis trial in Canadian Eskimos.

One hundred and two cases of inactive tuberculosis, 165 positive tuberculin reactors and 103 previous BCG vaccinated individuals showing large tuberculin reactions were placed on the completely supervised regimen consisting of isoniazid and ethambutol given three times a week. Over 90% of these individuals completed 18 months' treatment. There were no active cases of tuberculosis among the treated groups during the observation period averaging 34.8 months. The control groups consisting of 217 individuals had 9 cases of active tuberculosis giving an annual risk of developing the disease of 1.8 per 1000.

Adult↗

Lifelong follow-up of inactive tuberculosis: its value and limitations.

There are 14,552 inactive cases of tuberculosis in British Columbia, representing 0.6 per cent of the population. The prevalence of inactive tuberculosis in 7 times higher among Indians than in the remainder of the population. Among all inactive cases, 60.5 per cent of patients had "good" chemotherapy, whereas 13.2 per cent had poor chemotherapy and 26.3 per cent had no chemotherapy. The risk of reactivation in those who received "good" chemotherapy was 2.2 cases per 1,000 persons per annum, whereas for those with poor and no chemotherapy, the risks were 7.8 and 6.7 cases per 1,000 persons per annum, respectively. One third of a sample of all inactive cases were found not to comply with the existing policy of lifelong annual examinations. Of the remaining two-thirds, one-half attended regularly and one-half, irregularly. All reactivations occurring during the 3-year period between 1971 and 1973 were reviewed. The pattern of attendance of these patients during a 3-year period immediately before the year of reactivation was similar to that of the sample of all inactive cases. Sixty per cent of reactivations occurring among "attenders" were diagnosed at such annual examinations. The bacteriologic status of reactivated disease was reviewed; 78 per cent were culture positive. Of patients who had received previous chemotherapy, 45 per cent had organisms that were resistant to one or more of the 3 primary antituberculous drugs, whereas previously untreated groups showed a much lower figure, 7.8 per cent. On the basis of the findings of this study, recommendations are made in relation to future policy of management of inactive cases of tuberculosis.

Adolescent↗

Rifampin.

Rifampin is a potent antituberculous drug. In the treatment of drug-resistant tuberculosis it is highly effective provided it is given in combination with other drugs to which the patient's organisms are sensitive. Rifampin and ethambutol is a particularly powerful combination and will achieve almost 100% sputum conversion. It seems likely that rifampin will replace streptomycin, and ethambutol will replace PAS in first-treatment cases. Optimum first-line treatment will thus consist of rifampin, INH and ethambutol, with the probability of almost 100% success and the possibility also that the total duration of treatment may be considerably reduced. Rifampin is well tolerated but it may give rise to liver dysfunction and thrombocytopenia in a small proportion of patients. Patients treated with rifampin must be kept under close supervision because of the risk of side effects and, more important, because irregular treatment may lead to the development of rifampin-resistant organisms.

Adult↗

A double-blind trial of disodium cromoglycate (Intal) in the treatment of bronchial asthma.

The result of a double-blind crossover trial with disodium cromoglycate (Intal) in 22 patients, nine with extrinsic asthma and 13 with intrinsic asthma, is reported. While eight extrinsic asthmatics showed considerable symptomatic improvement, only five of the intrinsic group improved while on disodium cromoglycate. Twelve out of 13 patients with symptomatic improvement had associated decrease in airway obstruction as measured by the FEV(1).It is concluded that disodium cromoglycate is useful in the treatment of asthma, particularly of the extrinsic type.

Adult↗

Bronchial reactions to western red cedar (Thuja plicata).

The clinical features and the results of investigations (including immunological tests) of three patients with asthma due to western red cedar are described. Bronchial provocation tests with extract of this wood produced immediate asthmatic reaction in one patient, late asthmatic and peripheral reactions in another and late asthmatic reaction alone in the third. While mild immediate skin reactions were detected in two patients, no late skin reactions were observed. Serum precipitins to this extract were not detected. An attempt was made to identify the responsible allergen in the red cedar extract.

Adult↗